These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 2650821
1. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure. Lefer AM. Crit Care Clin; 1989 Apr; 5(2):331-52. PubMed ID: 2650821 [Abstract] [Full Text] [Related]
2. Platelet activating factor (PAF) and its role in cardiac injury. Lefer AM. Prog Clin Biol Res; 1989 Apr; 301():53-60. PubMed ID: 2678133 [Abstract] [Full Text] [Related]
6. Alterations in nitric oxide production in various forms of circulatory shock. Szabó C. New Horiz; 1995 Feb; 3(1):2-32. PubMed ID: 7535648 [Abstract] [Full Text] [Related]
10. Detection of platelet-activating factor during traumatic shock. Stahl GL, Craft DV, Lento PH, Lefer AM. Circ Shock; 1988 Nov; 26(3):237-44. PubMed ID: 3208421 [Abstract] [Full Text] [Related]
11. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock]. Marzi I, Bauer M, Reisdorf E, Walcher F. Zentralbl Chir; 1994 Nov; 119(11):814-21. PubMed ID: 7846961 [Abstract] [Full Text] [Related]
12. Platelet Activating Factor antagonists. Afroz S, Ara A, Arif M. Pak J Pharm Sci; 1998 Jul; 11(2):5-12. PubMed ID: 16414813 [Abstract] [Full Text] [Related]
13. Platelet activating factor: the good and the bad in the ischemic/reperfused heart. Penna C, Bassino E, Alloatti G. Exp Biol Med (Maywood); 2011 Apr 01; 236(4):390-401. PubMed ID: 21378031 [Abstract] [Full Text] [Related]
14. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. Sun XM, Hsueh W. J Immunol; 1991 Jul 15; 147(2):509-14. PubMed ID: 2071893 [Abstract] [Full Text] [Related]
16. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. Ko W, Lang D, Hawes AS, Zelano JA, Isom OW, Krieger KH. J Surg Res; 1993 Nov 15; 55(5):504-15. PubMed ID: 8231170 [Abstract] [Full Text] [Related]
17. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. Mencia-Huerta JM, Lewis RA, Razin E, Austen KF. J Immunol; 1983 Dec 15; 131(6):2958-64. PubMed ID: 6315819 [Abstract] [Full Text] [Related]
18. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Ma X, Bazan HE. Invest Ophthalmol Vis Sci; 2000 Jun 15; 41(7):1696-702. PubMed ID: 10845588 [Abstract] [Full Text] [Related]
19. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility. Delbridge LM, Stewart AG, Goulter CM, Morgan TO, Harris PJ. J Mol Cell Cardiol; 1994 Feb 15; 26(2):185-93. PubMed ID: 8006979 [Abstract] [Full Text] [Related]
20. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. Doebber TW, Wu MS, Biftu T. J Immunol; 1986 Jun 15; 136(12):4659-68. PubMed ID: 3011900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]